Affordable Access

Letter from David J. Galas, United States Department of Energy to Joshua Lederberg

Authors
Publication Date
Disciplines
  • Biology
  • Economics
  • Political Science

Abstract

Department of Energy Washington, DC 20585 Jut 1 6 1992 Dr. Joshua Lederberg The Rockefeller University 1230 York Avenue New York. NY LOOZl-6399 Deam Whzn the President's budget for Fiscal Year 1993 was announced in January 1992, Biotechnology Research was declared a Presidential Initiative in recognition of the importance of the biological research arena for the future of the scientific, technological, and economic health of the U.S. A report called Biotechno7ogy for the Zlst Century was released at that time which described and supported the Presidential Federal budget for biotechnology research of $4.03 billion for Fiscal Year 1993. The initiative and the report were the products of an intensive, year-long effort by the 12 participating agencies (see enclosed report). While this report does indeed represent a major effort, and the first systematic compilation and analysis of Federal programs and budgets in biotechnology research and infrastructure, we fully recognize that it is just a beginning. In the next few months, the Committee responsible, which I chair, the Biotechnology Research Subcommittee (BRS) of the Committee on Life Sciences and Health, will be reviewing and revisiting the general schema and the eight priorities that were established by us for Biotechnology Research (see pages 8 through 13 of the report). We will be examining the priority and relevance of these recommendations, and attempting to define some concrete objectives for implementing them in the Federal program. My purpose in writing you is to request your assistance in reviewing the initial report and especially in helping to shape the character of the program for Federally supported biotechnology research. We are asking selected leading experts external to the government, in academic and industrial research, and in other relevant areas, to provide us with their views that can help guide us in shaping the Federal Biotechnology Research Initiative. I would ask that

There are no comments yet on this publication. Be the first to share your thoughts.